Skip to main content
. 2024 Jan 2;24:39. doi: 10.1186/s12879-023-08946-x

Table 2.

Gram-positive and Gram-negative bacteria in spinal infections

Entities, complications, and primary source of infection (n = 187) Gram-positive bacteria
(n = 162, 86.6%)
Gram-negative bacteria
(n = 25, 13.4%)
p-value*
SD 105/162 (64.8%) 20/25 (80.0%) 0.172
ISEE 57/162 (35.2%) 5/25 (20.0%)
Sepsis 81/162 (50.0%) 13/25 (52.0%) 1.0
Septic embolism 46/128 (35.9%) 4/22 (18.2%) 0.142
Endocarditis 23/139 (16.5%) 0/22 (0.0%) 0.046
Relapse rate 22/103 (21.4%) 6/20 (30.0%) 0.394
Disease-related mortality 9 (5.6%) 1 (4.0%) 1.0
Source of infection (129/187, 69.0%)
Hematogenous spread < 0.001 (1)
Gastrointestinal tract infection 6/107 (5.6%) 3/22 (13.6)
Respiratory tract infection (pneumonia) 15/107 (14.0%) 1/22 (4.5%)
Urinary tract infection (urosepsis) 4/107 (3.7%) 9/22 (40.9%)
Skin infection 34/107 (31.8%) 3/22 (13.6%)

Foreign body-associated infection

(joint replacements, venous access port, prosthetic heart valve, and screws elsewhere in spine)

20/108 (18.7%) 3/22 (13.6%)
Odontogenic infection 5/107 (4.7%) 0/22 (0.0%)
Retropharyngeal & prevertebral infection 4/107 (3.7) 2/22 (9.1%)
Post-interventional
Epidural administration such as spinal infiltration (facet joint, epidural, periradicular) or epidural catheter analgesia 19/107 (17.8%) 1/22 (4.5%)

Bold values are significant results (p < 0.05) as indicated in the methods, SD: spondylodiscitis, ISEE: isolated spinal epidural empyema, *Fisher exact test